Adalimumab Earns FDA Approval for Ulcerative Colitis in Children
Adalimumab has received approval from the Food and Drug Administration for use in pediatric patients aged 5 years and older …
Home »
Adalimumab has received approval from the Food and Drug Administration for use in pediatric patients aged 5 years and older …
Blood clots are the biggest cause of death in patients with inflammatory bowel disease (IBD)—ulcerative colitis or Crohn’s disease. In …